AR023300A1 - COMPUESTOS HETEROETINILENADOS, COMPOSICIONES FARMACÉUTICAS Y COSMÉTICAS QUE LOS COMPRENDEN Y UTILIZACIoN COSMÉTICA DE LA COMPOSICIoN COSMÉTICA PARA LA HIGIENE CORPORAL O CAPILAR. - Google Patents
COMPUESTOS HETEROETINILENADOS, COMPOSICIONES FARMACÉUTICAS Y COSMÉTICAS QUE LOS COMPRENDEN Y UTILIZACIoN COSMÉTICA DE LA COMPOSICIoN COSMÉTICA PARA LA HIGIENE CORPORAL O CAPILAR.Info
- Publication number
- AR023300A1 AR023300A1 ARP990101391A ARP990101391A AR023300A1 AR 023300 A1 AR023300 A1 AR 023300A1 AR P990101391 A ARP990101391 A AR P990101391A AR P990101391 A ARP990101391 A AR P990101391A AR 023300 A1 AR023300 A1 AR 023300A1
- Authority
- AR
- Argentina
- Prior art keywords
- radical
- hydrogen atom
- given below
- lower alkyl
- cosmetic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/54—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and unsaturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C391/00—Compounds containing selenium
- C07C391/02—Compounds containing selenium having selenium atoms bound to carbon atoms of six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
Compuesto heteroetinilenados que responden a la formula general (1) en la cual R1 representa: (i) el radical-CH3, (ii) el radical -CH2-O-R5, (iii) elradical -COR6, y donde R5 y R6 los significados dados a continuacion, -X representa: O, Se, S(O)n,s iendo n 0, 1 o 2, -Y representa un radical divalente quetiene formula a), b), c), d), teniendo R7, R8, R9 y R10 los significados dados a continuacion, R2 y R3 tomados juntos con el ciclo aromático adyacente un ciclode 5 o 6 eslabones eventualmentesu stituido por grupos metilo y/o eventualmente interrumpido por un átomo de oxígeno o de azufre, sabiendo que R2 y R3independientemente idénticos o diferentes pueden representar: a) un átomo de hidrogeno, b) un radical seleccionado entre losradicales metilo, tertiobutilo, 1-metilciclohexilo, 1, adamantilo, c) un radical-OR11, d) un radical poliéter, e) un átomo de halogeno, teniendo R11 el significado dado a continuacion,entendiéndose que al menos uno de los sustituyentes R2 y R3representan (b), R4 representa un átomo de hidrogeno un radical alquilo inferior, un radical OR12,un radical polieter, un radical COR13, o un átomo de halogeno, teniendo R12 y R13 los significados dados a continuacion, R4 representa un átomo dehidrogenoo un átomo d e halogeno; R5 representa un átomo de hidrogeno o un radical alquilo inferior, R6 representa:(i)un átomo de hidrogeno; (ii) un radical alquilo inferior; (iii) el radical OR14, teniendo R14 el significado dado a continuacion,(iv) el radical de formul a (2)teniendo R y R los significados dados a continuacion, R7, R8 R9 y R10 idénticos o diferentes representan un átomo de hidrogeno, un radical alquilo inferior,o un radical arilo, R11 y R12 idénticos o diferentes,representan un átomo de hidrogeno, un radical alquilo inferior, un radical arilo eventualmente sustituidoun radical aralquilo eventualmente sustituido, un radical monohidroxialquilo o polihidroxialquilo o un radical acilo inferior. R13 representa unradical
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9803977A FR2776659B1 (fr) | 1998-03-31 | 1998-03-31 | Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR023300A1 true AR023300A1 (es) | 2002-09-04 |
Family
ID=9524692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990101391A AR023300A1 (es) | 1998-03-31 | 1999-03-29 | COMPUESTOS HETEROETINILENADOS, COMPOSICIONES FARMACÉUTICAS Y COSMÉTICAS QUE LOS COMPRENDEN Y UTILIZACIoN COSMÉTICA DE LA COMPOSICIoN COSMÉTICA PARA LA HIGIENE CORPORAL O CAPILAR. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US6444709B1 (es) |
| EP (1) | EP0986537B1 (es) |
| JP (1) | JP3419467B2 (es) |
| AR (1) | AR023300A1 (es) |
| AT (1) | ATE221874T1 (es) |
| AU (1) | AU740863B2 (es) |
| BR (1) | BR9904890A (es) |
| CA (1) | CA2291650C (es) |
| DE (1) | DE69902427T2 (es) |
| DK (1) | DK0986537T3 (es) |
| ES (1) | ES2184424T3 (es) |
| FR (1) | FR2776659B1 (es) |
| NO (1) | NO995838L (es) |
| PT (1) | PT986537E (es) |
| WO (1) | WO1999050239A2 (es) |
| ZA (1) | ZA997511B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2801305B1 (fr) * | 1999-11-24 | 2002-12-06 | Galderma Res & Dev | Analogues de la vitamine d |
| FR2840300B1 (fr) * | 2002-06-04 | 2004-07-16 | Galderma Res & Dev | NOUVEAUX LIGANDS INHIBITEURS DES RECEPTEURS RARs, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE |
| WO2003101945A1 (en) * | 2002-06-04 | 2003-12-11 | Galderma Research & Development, S.N.C. | Ligands that are inhibitors of the rar receptors |
| EP1771163A1 (en) * | 2004-07-29 | 2007-04-11 | Werner Bollag | Rxr antagonist treatment against multiple sclerosis |
| EP1621191A1 (en) * | 2004-07-29 | 2006-02-01 | Werner Bollag | Treatment of inflammatory diseases by RXR Antagonists |
| US20090128307A1 (en) | 2004-09-16 | 2009-05-21 | Daimlerchrysler Ag | Display device and display method for a vehicle |
| FR2910320B1 (fr) | 2006-12-21 | 2009-02-13 | Galderma Res & Dev S N C Snc | Emulsion comprenant au moins un retinoide et du peroxyde de benzole |
| FR2910321B1 (fr) | 2006-12-21 | 2009-07-10 | Galderma Res & Dev S N C Snc | Gel creme comprenant au moins un retinoide et du peroxyde de benzole |
| FR2931661B1 (fr) | 2008-05-30 | 2010-07-30 | Galderma Res & Dev | Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide. |
| CN112010795A (zh) * | 2020-08-12 | 2020-12-01 | 温州医科大学 | 一种2-炔硒基环己醇化合物的合成方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2719043B1 (fr) * | 1994-04-26 | 1996-05-31 | Cird Galderma | Nouveaux composés bicycliques-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations. |
| FR2741878B1 (fr) * | 1995-12-01 | 1998-01-09 | Cird Galderma | Composes biaromatiques portant un groupement adamantyl en ortho, compositions pharmaceutiques et cosmetiques les contenant et utilisations |
-
1998
- 1998-03-31 FR FR9803977A patent/FR2776659B1/fr not_active Expired - Fee Related
-
1999
- 1999-03-29 ES ES99910451T patent/ES2184424T3/es not_active Expired - Lifetime
- 1999-03-29 AR ARP990101391A patent/AR023300A1/es active IP Right Grant
- 1999-03-29 BR BR9904890-6A patent/BR9904890A/pt not_active IP Right Cessation
- 1999-03-29 WO PCT/FR1999/000727 patent/WO1999050239A2/fr active IP Right Grant
- 1999-03-29 DE DE69902427T patent/DE69902427T2/de not_active Expired - Lifetime
- 1999-03-29 AT AT99910451T patent/ATE221874T1/de active
- 1999-03-29 AU AU29402/99A patent/AU740863B2/en not_active Ceased
- 1999-03-29 JP JP54897099A patent/JP3419467B2/ja not_active Expired - Fee Related
- 1999-03-29 DK DK99910451T patent/DK0986537T3/da active
- 1999-03-29 PT PT99910451T patent/PT986537E/pt unknown
- 1999-03-29 CA CA002291650A patent/CA2291650C/fr not_active Expired - Fee Related
- 1999-03-29 EP EP99910451A patent/EP0986537B1/fr not_active Expired - Lifetime
- 1999-03-29 US US09/424,816 patent/US6444709B1/en not_active Expired - Lifetime
- 1999-11-29 NO NO995838A patent/NO995838L/no not_active Application Discontinuation
- 1999-12-07 ZA ZA9907511A patent/ZA997511B/xx unknown
-
2002
- 2002-07-11 US US10/192,651 patent/US6921777B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP3419467B2 (ja) | 2003-06-23 |
| PT986537E (pt) | 2002-12-31 |
| US6921777B2 (en) | 2005-07-26 |
| AU740863B2 (en) | 2001-11-15 |
| ATE221874T1 (de) | 2002-08-15 |
| AU2940299A (en) | 1999-10-18 |
| FR2776659A1 (fr) | 1999-10-01 |
| ZA997511B (en) | 2000-06-08 |
| WO1999050239A3 (fr) | 1999-11-18 |
| CA2291650A1 (fr) | 1999-10-07 |
| DE69902427D1 (de) | 2002-09-12 |
| WO1999050239A2 (fr) | 1999-10-07 |
| NO995838D0 (no) | 1999-11-29 |
| BR9904890A (pt) | 2000-09-19 |
| NO995838L (no) | 2000-01-31 |
| JP2001502722A (ja) | 2001-02-27 |
| DK0986537T3 (da) | 2002-12-02 |
| US6444709B1 (en) | 2002-09-03 |
| ES2184424T3 (es) | 2003-04-01 |
| DE69902427T2 (de) | 2002-12-12 |
| CA2291650C (fr) | 2006-05-16 |
| EP0986537B1 (fr) | 2002-08-07 |
| US20030012803A1 (en) | 2003-01-16 |
| EP0986537A2 (fr) | 2000-03-22 |
| FR2776659B1 (fr) | 2000-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR025225A1 (es) | Feniloxazolidinonas heterociclicas biciclicas sustituidas antibacterianas y composiciones farmacéuticas | |
| CO4700576A1 (es) | Nuevos taxoides, su preparacion y las composiciones farmaceuticas que los contienen | |
| HUP0302969A2 (hu) | NPY Y5 antagonisták, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| DE69007429D1 (de) | Isoindolonderivate, ihre Herstellung und diese enthaltende pharmazeutische Zusammensetzungen. | |
| DE69918404D1 (de) | Aminophenoxyessigsäure derivate als neuroschützende mittel | |
| AR023497A1 (es) | Ent-esteroides en calidad de estrogenos con efecto selectivo, su empleo para el tratamiento de las enfermedades y los estados motivados por una deficienciade estrogenos en la mujer y en el hombre, y las composiciones farmaceuticas que contienen estos ent-esteroides | |
| AR023300A1 (es) | COMPUESTOS HETEROETINILENADOS, COMPOSICIONES FARMACÉUTICAS Y COSMÉTICAS QUE LOS COMPRENDEN Y UTILIZACIoN COSMÉTICA DE LA COMPOSICIoN COSMÉTICA PARA LA HIGIENE CORPORAL O CAPILAR. | |
| ES2148916T3 (es) | Derivados del 3-(piperid-4-il)-1,2-benzoisoxazol y del 3-(piperazin-4-il)-1,2-benzoisoxazol como antipsicoticos. | |
| ES2192031T3 (es) | Nuevas amidas aromaticas, su procedimiento de preparacion y su aplicacion como medicamentos. | |
| AR043279A1 (es) | Analogos de la vitamina d, su utilizacion, composicion farmaceutica, composicion cosmetica y utilizacion de la composicion cosmetica | |
| AR016131A1 (es) | -oxazolidinonas triciclicamente substituidas, procedimientos para su preparacion, uso de dichos compuestos y medicamentos. | |
| ES2142773B1 (es) | Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida. | |
| AR015311A1 (es) | Compuestos diaril selenuros, composiciones farmaceuticas y composiciones cosmeticas que comprenden al menos uno de dichos compuestos y utilizacion de la composicion cosmetica | |
| AR004965A1 (es) | Procedimiento de preparacion de derivados de fenilimidazolidina | |
| TR199902350T2 (xx) | Yeni piridin t�revleri ve onlardan olu�an farmakotik bile�imler. | |
| DE68914917D1 (de) | Tetracyclische Antidepressiva. | |
| DE69928951D1 (de) | 2,3-dihydro-1h-isoindol-derivate verwendbar als dopamin-d3-rezeptor-modulatoren (antipsychotische mittel) | |
| KR950010873A (ko) | 화장품 | |
| SE8303913L (sv) | Heterocykliska foreningar | |
| AR029900A1 (es) | Compuestos derivados de n-(heterociclil)benceno- o piridinsulfonamida, procedimiento para su preparacion y medicamento y composicion farmaceutica que los contienen | |
| ES2234825T3 (es) | Nuevos derivados heterociclicos o bencenicos del acido lipoico, su preparacion y su aplicacion como medicamentos. | |
| DE3370619D1 (de) | Indole derivatives | |
| NO963854L (no) | Okulart spenningsnedsettende middel | |
| ATE502034T1 (de) | Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung | |
| ES2117558B1 (es) | Composicion oftalmica topica que comprende un derivado de 2-(4-(azolilbutil)-piperazinil-metil)-benzimidazol, principalmente para el tratamiento de la conjuntivitis alergica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |